drugset / Trial / NCT01649037

To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome

NCT01649037

RandomizedParallel-groupOpen-labelTreatment

Summary

All consecutive patients with liver cirrhosis having Acute Kidney Injury at admission or during hospitalization will be included in the study. The diagnosis of liver cirrhosis will be based on the clinical grounds including Laboratory tests, endoscopic evidence, imaging (Ultrasonography/computed tomography) findings, and liver histology, when available.

Timeline

Start
2012-08
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Noradrenaline Unknown 0.5 mg Intravenous
Comparator Terlipressin Peptide 0.5 mg Intravenous
Comparator Terlipressin Peptide 1 mg Intravenous
Comparator Terlipressin Peptide 1.5 mg Intravenous

Indications